Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Accenture boosts virtual filmmaking with investment in Vū Technologies Accenture (NYSE: ACN) has marked a significant milestone in the world of virtual production and filmmaking with its… byPallavi MadhirajuNovember 19, 2023